
Mabion S.A.
WSE:MAB.WA
Overview | Financials
Company Name | Mabion S.A. |
Symbol | MAB.WA |
Currency | PLN |
Price | 19.28 |
Market Cap | 311,609,125 |
Dividend Yield | 0% |
52-week-range | 15.8 - 24.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Krzysztof Kaczmarczyk |
Website | https://www.mabion.eu |
An error occurred while fetching data.
About Mabion S.A.
Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD